Doxycycline use in patients with lymphangioleiomyomatosis: biomarkers and pulmonary function response ,

OBJECTIVE: To assess blockade of matrix metalloproteinase (MMP)-2 and MMP-9, as well as the variation in FEV(1), in patients with lymphangioleiomyomatosis (LAM) treated with doxycycline (a known MMP inhibitor) for 12 months. METHODS: An open-label, single-arm, interventional clinical trial in which...

Descripción completa

Detalles Bibliográficos
Autores principales: Pimenta, Suzana Pinheiro, Baldi, Bruno Guedes, Kairalla, Ronaldo Adib, Carvalho, Carlos Roberto Ribeiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Pneumologia e Tisiologia 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075801/
https://www.ncbi.nlm.nih.gov/pubmed/23503480
http://dx.doi.org/10.1590/S1806-37132013000100002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075801/
https://www.ncbi.nlm.nih.gov/pubmed/23503480
http://dx.doi.org/10.1590/S1806-37132013000100002

Ejemplares similares